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Abstract: We describe the long-term complications six years after chemoradiotherapy in a 20-year 
old woman with nasopharyngeal carcinoma. We wanted to know whether the radiation dose was 
constant throughout the oral cavity, and thus uniformly affecting the corresponding dental and 
skeletal structures. Clinical and radiologic findings are described six years after chemoradiotherapy 
based on a two-dimensional computerized treatment planning system. This revealed radiation caries 
limited only to posterior teeth, proximal caries in the anterior teeth, limited but continuous salivary 
flow, mild periodontal infection, mild xerostomia, and a regenerative capacity of bones and the 
developmental process. The quantitative assessment of radiation delivered to the mandible revealed 
a high radiation dose in the posterior area and a minimal dose in the anterior area. This explains the 
differences in caries manifestation between the anterior and posterior teeth. According to the present 
study, individualized radiation fields, using a two-dimensional treatment planning system, result in 
restriction of severe damage of the dental and skeletal structures, which usually follows chemora-
diotherapy. Orthodontic treatment could be initiated according to individual patient needs.
Keywords: nasopharyngeal carcinoma, adolescence, radiotherapy, dental and skeletal 
complications
Introduction
Nasopharyngeal carcinoma (NPC) is rarely reported in children1–3 and is more often of 
undifferentiated type. Combined chemoradiotherapy is the treatment of choice for this 
malignancy, and has shown promising results.3–5 Overall survival rates of 50%–77% 
are reported.2–4 However, the high radiation doses needed to provide effective   treatment 
have resulted in long-term toxicity, with hard and soft tissue growth complications, 
particularly in young children who are still growing.4–5 Maxillofacial and dental 
abnormalities are well-known long-term chemoradiotherapy-related complications 
in children with head and neck cancer.6–11 Severity of the developmental disturbances 
are related to the patient’s age at the time of treatment. The younger the child, the 
more severe the abnormalities, especially in those under six years.7 Another factor 
influencing the severity of developmental disturbances is the radiation dose, with doses 
between 10 to 30 Gy leading to significant bone growth disturbance and arrested tooth 
development.12 According to Guyuron et al13 30 Gy can be considered to be a harmful 
dosage for the development of the maxillofacial bones, and 4 Gy harmful to devel-
opment of the soft tissues. Xerostomia, oral mucositis, and late visual and auditory 
toxicity have also been reported as frequent and potentially severe complications of 
radiotherapy.14,15 Although treatment-related skeletal and dental complications from 
a range of malignancies have been often reported in children, there are few published International Journal of General Medicine 2010:3 submit your manuscript | www.dovepress.com
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studies concerning those with NPC in children.2,16 In addition, 
oral health after NPC treatment was reported by Schwarz 
et al17 but not for children.
We report here on a 20-year-old woman with dental 
and maxillofacial skeletal complications six years after 
  chemoradiotherapy for NPC. The rarity of NPC in children 
and the absence of clear data regarding the safety of the radia-
tion dose delivered to the oral area makes this study of interest 
to all dentists and orthodontists involved in   improving quality 
of life for these young patients.
Materials and methods
A 20-year-old woman was referred by Radiation Oncology 
to our Orthodontics Department for dental assessment and 
subsequent orthodontic consultation and treatment. She 
had a known six-year history of histologically diagnosed 
NPC, (Type ΙΙ according to WHO criteria, cΤ3cΝ3Μ0, 
Grade Ι. She had been treated with chemoradiotherapy 
comprising concurrent cisplatin (100 mg/m2 on days 1, 22, 
and 43) chemoradiotherapy, followed by three cycles of 
adjuvant chemotherapy consisting of cisplatin 80 mg/m2 and 
5-  fluorouracil 500 mg/m2 at 28-day intervals.18 She did not 
receive any nonchemotherapeutic agents.
The radiotherapy plan was conducted using a two-
  dimensional computerized treatment planning system 
(Telemaque Technos, Technologies-Informatiques S.A., 
Trappes). The primary site and bilateral upper neck received 
60 Gy in 33 fractions over 6.5 weeks and the lower neck and 
supraclavicular fossae received 40 Gy in 22 fractions over 
4.5 weeks. A two-phase technique was used.
Following conventional simulation and using a Cobalt-60 
gamma ray unit, radiotherapy was initially delivered by large 
parallel-opposed lateral fields to a dose of 36 Gy given over 
four weeks at 180 cGy per day. The treatment field extended 
superiorly to the inferior orbital margin, inferiorly to the 
C6 spinous process, anteriorly to the anterior border of the 
masseter muscle, and posteriorly to the T2 spinous process, 
encompassing all macroscopic disease, including that in the 
spinal cord. To target undetectable microscopic disease, 
the clinical volume included the base of the skull,   posterior 
half of the nasal cavity, nasopharynx, sphenoid base, 
  parapharyngeal space, and lateral pharyngeal, and posterior 
and upper deep cervical nodes. The brainstem, optic chiasm, 
and anterior half of the orbit were shielded. During the second 
phase of treatment, the parallel-opposed lateral fields were 
reduced posteriorly to exclude the spinal cord, and a further 
dose of 24 Gy was given over 2.5 weeks, at 180 cGy per day, 
achieving a total dose of 60 Gy in 33 fractions.
In order to assess the delivered radiation dose on dental 
and skeletal structures in the present study, we used the central 
slice of the magnetic resonance imaging (MRI), including the 
mandibular teeth (Figure 1). The total radiation dose deliv-
ered was evaluated for the large parallel-opposed lateral field 
(Phase 1, Figure 2A) and for the reduced   parallel-opposed 
lateral field (Phase 2, Figure 2B) in   different levels represent-
ing mandibular tooth groups. Thus, the   internal volume 1 
(A) represents the central incisors, internal volume 2 (C) the 
canines, internal volume 3 (E) the second premolars, internal 
volume 4 (F) the first molars, internal volume 5 (G) the second 
molars, and internal volume 6 (H) the third molars. The isod-
ose calculation was conducted by the two-dimensional plan-
ning system for a 11 × 15 cm and a 7 × 15 cm 1.25 mV photon 
beam for Phase 1 and Phase 2 lateral fields, respectively. The 
isodose curves in Figure 2, which are the lines with the differ-
ent colors, corresponded to different percentages of the total 
dose delivered during both phases of radiotherapy.
Results
Radiation dose, as a percentage of the total dose, and total 
irradiation delivered are shown in Table 1. According to 
the isodose calculation, it appears that the delivered doses 
decreased from level 6, the nearest to the radiation field, to 
level 1, the most deviated. In summary, during Phase 1, the 
delivered dose at level 1 was 0% and at level 6 was 97%; for 
Phase 2, at level 1 the dose was 0% and at level 6 was 98%. 
Figure 1 Central slice of magnetic resonance imaging of the mandibular teeth.International Journal of General Medicine 2010:3 submit your manuscript | www.dovepress.com
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Figure 2 The two-dimensional planning system for isodose calculation for the large (A) and the reduced (B) parallel-opposed lateral fields and color curves showing the 
differences in radiation dose between posterior and anterior teeth during the two phases of radiotherapy.
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In total, the incisors received 0 Gy and the third molars 
received 58.44 Gy (Table 1).
The lower deep cervical and supraclavicular fossae 
lymph nodes were treated with a direct anterior photon field 
because of the position of the shoulders to a dose of 40 Gy 
in 22 fractions given over 4.5 weeks. A half-beam blocking 
technique was used along the superior margin of the anterior 
field to reduce divergence, central shielding to protect the 
spinal cord and larynx, and bilateral shielding to protect 
apical parts of both lungs.
Focusing on the anatomic structures of the jaw and oral 
cavity, the irradiated area at the midplane included the major 
salivary glands, mucosal surface, posterior part of the maxilla 
and of the body of the mandible to the anterior border of 
the masseter muscle, and the ramus of the mandible along 
with the coronoid process and the condyle. These structures 
received 50% of the prescribed dose at the lateral field mar-
gins, 95%–104% at the center of the fields, and less than 50% 
at the anterior part of the jaw.
In order to manage the expected xerostomia, the patient was 
advised to take frequent sips of water and maintain an adequate 
daily fluid intake. Sugar-free gums were used to stimulate 
saliva flow, and scrupulous oral hygiene was recommended. 
Moreover, amifostine, the most comprehensively tested 
  radioprotective agent, was utilized to prevent primarily radia-
tion-induced xerostomia and mucositis, providing protection 
for the salivary glands,19 as well as preventing   cisplatin-induced 
neurotoxicity, ototoxicity, and renal toxicity.
The size of the malignancy before and after treatment 
was estimated by MRI (Figures 3A, B, and C). A complete 
response, both of the primary tumor and locoregional lymph 
nodes, was achieved one month after the end of treatment 
(Figures 3D, E, and F).
Toxicity was evaluated according to WHO criteria   during 
and after treatment. Toxicity from chemotherapy was predom-
inantly Grade 2 nausea/vomiting and Grade 1   hematologic 
toxicity. The acute toxicity of radiotherapy consisted of 
Grade 2 mucositis and a Grade 2 skin reaction. Late compli-
cations of radiotherapy were mainly Grade 2 xerostomia and 
fibrosis in the soft tissues of the neck (Figure 4). Five years 
after radiotherapy, the complications were edema of the eye 
lids requiring   reconstructive surgery and hypothyroidism 
treated with thyroxine at a maintenance dose of 0.05 mg/
day orally, respectively.
Follow-up was scheduled every three months for the 
first two years, every six months for the next two years, and 
  annually thereafter. The patient remained disease-free six years 
post-chemoradiotherapy, and extraoral examination showed 
no apparent signs of deformity. Facial   examination showed no 
asymmetry in the frontal view (Figure 5A) and the soft tissue 
profile was acceptable (Figure 5B). Oral examination revealed 
that the patient had Class II, Division 1   malocclusion in her 
permanent dentition. Left first molars and left and right canines 
showed a Class I tooth   relationship, while the right first molars 
showed a Class III tooth relationship. The overjet was 7 mm, 
and the overbite 5 mm (Figures 6A, B, and C).
The maxilla was narrow anteriorly, maxillary anterior teeth 
were crowded, and the mandibular dental arch had spaces distal 
to the canines. Left maxillary and right and first left mandibu-
lar molars, as well as lower the right and third left molars, 
were extracted (Figures 6D and E). Multiple caries lesions 
were found in almost all teeth, but the lesions of the canines, 
premolars, and molars were more significant. Maxillary and 
mandibular posterior teeth showed Class I caries and enamel 
decalcification, while the anterior teeth showed proximal, 
distal, and mesial caries. No cervical caries on the anterior or 
posterior teeth was evident. The patient’s oral hygiene was 
poor, with plaque accumulation, severe localized inflammatory 
gingivitis, and gingival hyperplasia (Figure 6).
Comparison of two panoramic radiographs at the end 
of chemoradiotherapy (Figure 7A) and six years later 
(Figure 7B) revealed that the third mandibular molars 
Table 1 Isodose calculation for the large (A), and the reduced (B) parallel-opposed lateral fields with the different percentages of the 
total dose delivered on the mandibular teeth
Teeth large parallel- 
opposed l
Lateral field (Phase 1) 
(total dose 36 Gy,%) 
Reduced parallel-opposed lateral  
field (Phase 2) (total dose 24 Gy,%) 
Total (Gy) 
Central incisor (A)  0  0  0.0 
Lateral incisor  1  1  0.6 
Canine (C)  2  2  1.2 
First premolar  5  5  3.0 
second premolar (e)  15 15  9.0 
First molar (F)  45 30  23.4 
second molar (G)  85 85  51.0 
Third molar (H)  97 98  58.4 International Journal of General Medicine 2010:3 submit your manuscript | www.dovepress.com
Dovepress 
Dovepress
191
Chemotherapy-related complications of nasopharyngeal carcinoma
Figure 3 Magnetic resonance imaging showing the size of the malignancy before treatment with chemoradiotherapy (A, B, C), and the response after treatment (D, E, F).
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were presented initially. They were, however, extracted 
after chemoradiotherapy prior to the start of six-year 
follow-up. The extraction spaces of the left maxillary and 
right and left mandibular first molars were not totally closed 
  initially (Figure 7A). During the six years of follow-up, the 
  corresponding first molars were moved forward to close the 
remaining spaces, but with significant mesial inclination (left 
maxillary and right mandibular first molar) accompanied 
by periodontal pockets located at the mesial aspect of their 
mesial roots (Figure 7B). Six years after chemoradiotherapy, 
the right and left third maxillary molars showed good posi-
tioning in the dental arch, the pulp chamber was formed and 
the apex was fully closed, although the later was not evident 
immediately after chemoradiotherapy.
A
Figure  4  soft  tissue  fibrosis  of  the  neck  in  frontal  (A)  and  lateral  (B)  views 
immediately after treatment with chemoradiotherapy.
B
A
Figure 5 extraoral photographs (A, frontal view; B, lateral view) of the patient six 
years after chemoradiotherapy, showing no alterations of facial proportions and 
symmetry.
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A B
C D
Figure 6 Intraoral photographs of the patient six years after chemoradiotherapy showing occlusal relationships, radiation caries in posterior teeth, proximal caries in anterior 
teeth, inflammatory gingivitis, and gingival hyperplasia (A, right view; B, frontal view; C, left view; D, maxillary dental arch; E, mandibular dental arch).
EInternational Journal of General Medicine 2010:3 submit your manuscript | www.dovepress.com
Dovepress 
Dovepress
194
Ioannidou-Marathiotou et al
It was also observed that, during the same follow-up 
period, six endodontic treatments were performed in a total 
of 27 preserved teeth. Bone density and mandible bone 
  volume did not seem to differ from the non-irradiated bones. 
In addition, no apparent signs of radionecrosis were evident. 
Furthermore, following extraction of the third molars after 
chemoradiotherapy, normal bone healing was observed at 
the corresponding extraction sites (Figure 7B).
Cephalometric analysis revealed maxillary protrusion 
in relation to the anterior skull base, mandibular retru-
sion, a dolichofacial growth pattern, normal lower facial 
height,   normal mandibular length, and anterior rotation of 
the   mandible. Lower incisors were positioned at a normal 
  distance to the A-Pog plane, but with lingual inclination. 
The lower lip was found in a posterior position in relation to 
the esthetic line, and the nose seemed pronounced (Figure 8, 
Table 2).
Discussion
Chemoradiotherapy has improved the cure rates for childhood 
head and neck malignancies. Concomitant   chemotherapy 
enhances the effects of radiotherapy, resulting in improved 
outcome in NPC, but with a significant increase in acute 
toxicity, especially mucositis, due to the use of cisplatin as 
a radiosensitizer.20
Direct and indirect long-term radiation effects on   developing 
organs have been reported in long-term survivors.11,17,21 The 
effects of chemotherapy appear to be similar to those reported 
for irradiation, although generally milder.20
In our patient, long-term chemoradiotherapy-related 
effects on dental development were compared only in 
the limited area of posterior teeth, because the first pan-
oramic radiograph was of poor quality, 9,5 of as high as 
60 Gy, did not significantly affect completion of their root 
formation.
Another interesting observation was the deterioration of 
enamel structure and development of caries lesions. Caries 
development in patients treated for cancer is attributed to 
post-radiation xerostomia and its duration.11,17,23–25 In the 
present patient, radiation caries was present mainly in the 
posterior maxillary and mandibular teeth. Minor caries was 
observed on the anterior teeth of both dental arches, located 
mainly in their proximal, mesial, and distal aspects. Cervical 
caries indicative of xerostomia, usually manifested as an indi-
rect effect post-irradiation, was not evident. This difference 
in caries manifestation between the anterior and posterior 
teeth could be attributed to the difference in the radiation 
dose received by different tooth groups, achieved by the 
two-dimensional planning system. Consequently, although 
caries of the posterior teeth can be attributed to radiation, 
the corresponding caries lesions in the anterior teeth are not 
related to radiation-xerostomia effects for two main reasons, 
ie, the high radiation dose was limited in the posterior teeth, 
mainly on the second and third molars, and the submandibular 
and sublingual salivary glands were out of the radiation field 
and therefore were not affected by radiation, thus obtaining 
restricted but continuous saliva flow. It is probable that the 
caries present six years after chemoradiotherapy in our patient 
was due to poor oral hygiene.
No major skeletal problems attributable to radiotherapy 
were found in our patient. On the contrary, a more significant 
degree of aberrant skeletal effects has been expected because 
the patient received 60 Gy on the upper neck and 40 Gy on 
the lower neck, and bone growth damage has been reported to 
occur at doses of 10 to 30 Gy,12 and micrognathia at doses of 
35 Gy.26 The lack of major skeletal effects is probably due to 
the age of this patient at time of irradiation (14 years) when 
maxillary growth was almost complete and only residual 
mandible growth potential remained, probably leading to 
development of the mandibular retrusion observed six years 
after chemoradiotherapy. However, the patient’s normal 
mandible sagittal linear value, symphysis morphology, and 
pogonion prominence six years after treatment, indicates that 
some compensation had occurred and that a developmental 
effect existed post-irradiation.
Figure 7 Panoramic radiographs immediately after chemoradiotherapy (A), and six 
years later (B).
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Moreover, it seems that the present dental and skeletal rela-
tionships in our patient are more the result of evolution of a pre-
existing malocclusion than the effect of chemoradiotherapy.
Finally, at the present time, mandible bone density and 
volume in this patient do not seem to be adversely affected, 
osteoradionecrosis is not apparent, and bone regenerative 
capacity had been preserved after third molar extraction 
post-chemoradiotherapy.
Use of individualized radiation fields by means of a two-
dimensional computerized treatment planning system in our 
patient limited the severe damage to maxillofacial, dental, and 
skeletal structures that usually follows chemoradiotherapy. 
Teeth and bones were mildly affected, but with an appropri-
ate long-term follow-up program for oral hygiene and an 
oral care protocol,27 orthodontic treatment could be initiated 
according to the needs of individual patients.
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